SHR8735-303 A Randomized, Multi-Center, Double Blind, Phase III Study evaluating the efficacy and safety of Hetrombopag Olamine Tablets vs Placebo in patients with chemotherapy induced Thrombocytopenia.



Mary Beth Wilwerding, RN Admin@NEcancertrials.com



Available at Cancer Partners of Nebraska, Lincoln, NE location

Interested in More Information?

Please fill out the form below. Someone will get back to you as soon as possible.

"*" indicates required fields

Name*

Email*

Phone*

Message*